ABM

Why Your ABM Strategy Isn’t Converting (And How to Fix It)

Adriaan ten Boosch

6 min read

·

ABM underperforms when the account list is built on fit. Fit tells you which companies could buy from you. It does not tell you which companies have a live pain your team can address this quarter.

Three things change conversion rates in ABM:

  1. Replace fit-based account selection with evidence-based account selection. The account list should reflect companies showing active signals of a specific problem, not companies that resemble your best customers.

  2. Align the play before the campaign. Marketing and Sales should agree on which buying unit owns the pain and which play they are running, before the first ad impression or the first outbound sequence.

  3. Give the account list a reason, not just an argument. The evidence behind each account selection should be visible to both functions. If Marketing does not know why Sales added an account, the campaign does not know which pain to address.

ABM is one of the few GTM motions where the upstream decision about which accounts to target matters more than the downstream execution of how to reach them. Most underperforming ABM programs have excellent execution and poor targeting.

What ABM looks like in most organizations

Every quarter, a VP of Marketing and a CRO walk into an account list review.

They start with the named accounts from the CRM. Add some accounts from a recent ICP analysis. Pull in the 6sense or Bombora accounts showing intent. Filter by company size, industry, and region. Maybe add a few accounts the CRO mentioned from a recent conference.

The result is a list of 200 to 500 accounts. Marketing will run display ads, content syndication, and sponsored content against that list. Sales will build cadences and start outreach.

Six months later, the list has generated some website visits, a few content downloads, some meeting requests that didn’t convert, and a handful of deals that were probably already in the pipeline before ABM started.

The attribution is murky. Whether ABM worked is hard to answer because what “working” meant was never clearly defined upfront.

This is not a technology problem. The platforms are functional. The problem is the list.

The fit trap

Most ABM programs select accounts by asking: does this company look like our ideal customer?

They score against firmographic criteria. Industry, company size, revenue, geography, employee count, technology stack. They pull intent data to add a layer of “they’re researching something.” They add high-profile logos that sales leadership wants to pursue.

The result is a list of companies that could buy from you. That is a much longer list than it needs to be, and it is not the same list as companies that are ready to buy from you now.

The distinction sounds academic until you look at conversion rates. ABM programs targeting fit-based lists typically show strong engagement metrics (visits, downloads, form fills) and weak pipeline contribution. Accounts engage with content. They do not engage with sales conversations. Because the timing is wrong.

Fit is not timing. Intent data is closer to timing, but it is not specific enough. “An account is researching sales intelligence” is not a reason to run a campaign. “An account’s new VP of Sales just posted three BDR hiring roles in markets where they are currently underperforming, and their last earnings call mentioned sales capacity as a growth constraint” is a reason.

Three structural failures

Marketing and Sales are targeting different things.

Marketing selects accounts based on ICP fit and intent signals. Sales adds accounts based on rep territory knowledge and recent conversations. The two lists overlap by 40 to 60 percent in most organizations. The remaining accounts are worked by one function but not the other.

The accounts where Sales has context but Marketing isn’t running campaigns don’t benefit from coordinated ABM. The accounts where Marketing is running campaigns but Sales doesn’t prioritize them get impressions without follow-up. Neither set converts well.

The play is not agreed before the campaign.

ABM content is usually demand generation content adapted for the target account list. It speaks to general pain without knowing whether the Operations buying unit or the Finance buying unit is the actual target.

Reps follow up without a specific play in mind. The campaign and the outreach are not coordinated at the play level. Marketing talks about one problem. Sales talks about another. The buyer sees two different conversations from the same vendor.

The evidence disappears after account selection.

When Marketing selects accounts in Q1, the intent signals and ICP reasoning that drove those selections are not recorded and shared with Sales. By the time a rep touches the account in Q2, there is no context for why this account was prioritized.

The rep does not have the “why now” story. The first outreach is generic. The campaign investment does not translate into a compelling conversation.

A concrete example

Two ABM programs targeting the same segment: mid-to-large enterprise software companies.

Program A (fit-based)

List built from: companies with 500 to 5,000 employees, SaaS revenue model, EU or US headquarters, Salesforce as CRM, intent surging on “sales intelligence” or “ABM.” 420 accounts.

Content: generic demand generation about modern ABM practices. Display ads on LinkedIn and programmatic channels.

Six-month results: 12% of target accounts visited the website. 2% completed a content download. 0.4% requested a meeting. 3 deals influenced, all of which had Sales conversations predating the campaign.

Program B (evidence-based)

List built from: companies showing three or more of the following signals in the last 60 days. New CRO or VP Sales hired. BDR team headcount increased by 30% or more. Public statement about territory expansion or scaling outbound. Job postings indicating ABM or Sales Ops investment. Named account list motion visible from job descriptions or LinkedIn activity.

List size: 60 accounts. Each account has a specific reason for inclusion. Sales knows the reason. Marketing knows the reason. The campaign brief references which pain signal drove the inclusion.

Six-month results: 28% of target accounts engaged with Sales. 18% had a substantive discovery conversation. 9% entered the pipeline.

Same platforms. Same team. Different lists. Very different outcomes.

Diagnostic

You probably have an ABM targeting problem if:

  • Your ABM list has more than 300 accounts and most of them do not have a specific “why now” reason for being included.

  • Marketing and Sales are reporting different accounts as the highest-priority targets this quarter.

  • Your ABM engagement metrics (impressions, visits, downloads) are high but pipeline contribution is low.

  • When you ask Sales why a specific account is on the list, the answer is “they fit our ICP.”

You probably do not have this problem if:

  • You have a small named-account motion with fewer than 100 accounts where Sales has tight, current territory knowledge.

  • Your inbound pipeline is healthy enough that ABM is supplementary, not load-bearing for the quarter.

What working ABM requires

Four things most programs are missing:

An account selection process that requires evidence, not just fit. Every account on the list should have at least one specific, recent signal attached to it. If you cannot answer “why this account, why now,” it should not be on the active list.

Play alignment before campaign execution. Marketing and Sales should agree, per account, on which buying unit the campaign targets and which play Sales will run when an account engages. This requires a shared view of the plays the company runs and what evidence maps to each one.

The evidence attached to the account record. Not just the account name. The reason. The signals. The buying unit. The play. Both functions should be able to see this at any time, so the rep and the campaign are reading from the same brief.

A tighter list, not a bigger one. The natural instinct is to add accounts to improve coverage. The right instinct is to remove accounts that do not have evidence of a live pain. A 60-account list with strong conviction consistently outperforms a 400-account list built on fit.

Account selection: four filters

Before adding any account to an ABM list, apply four filters:

Filter

Question

Live signal

Is there at least one external signal from the last 60 days pointing to an active pain?

Buying unit

Which buying unit owns the pain, based on the signal?

Play

Which of our plays addresses this pain in this buying unit?

Sales alignment

Has Sales agreed on the play and the buying unit for this account?

If any filter returns “don’t know,” the account goes on a watch list, not the active list.

FAQ

Why is ABM not converting for most enterprise sales teams?
Usually because the account list is built on fit rather than evidence of a live pain. Fit-based ABM targets the right type of companies. Evidence-based ABM targets the right companies at the right time. The difference shows up in pipeline quality, not in engagement metrics.

What makes an ABM account list accurate?
Every account should have a specific, recent external signal indicating that a problem the team can solve is active now. Job postings, exec changes, public statements, technology purchases, and financial filings can all point to live pain. Without this, the list is a bet on potential rather than a conclusion about timing.

How should Sales and Marketing align on ABM accounts?
Both functions should share the same account selection criteria and the same evidence for each account. Sales should know which play Marketing is supporting with campaigns. Marketing should know which buying unit Sales plans to target. When they operate from different information, conversion rates suffer regardless of execution quality.

What is the right size for an ABM account list?
Smaller than most teams think. A list of 50 to 100 accounts with strong conviction and play alignment outperforms a list of 400 accounts built on fit. The quality of each account selection matters more than coverage.

ABM is not a distribution strategy. It is a targeting decision. The distribution part, ads, content, sequencing, works when the targeting is right.

The targeting is usually wrong. Not because the team is incompetent. Because the evidence layer that would make it right does not exist in most organizations.

The fix is not a better platform or a bigger budget. It is an evidence layer that connects external signals to specific plays, specific buying units, and a list of accounts where the timing is actually right.

A 60-account list where every account belongs beats a 400-account list where most of them don’t.

Rembrandt is the GTM intelligence layer for enterprise revenue teams. We help Sales and Marketing select accounts based on evidence, not fit, so ABM runs into the right buying units with the right plays. See how it works.

In enterprise, AI will only replace guesswork.

No Pain. No Pipeline.

Discover more in a quick 30-min call today.

Light where it matters.

Mindmapp BV, 1017 VN, Weesperstraat 107, Amsterdam, the Netherlands

Rembrandt

REMBRANDT — THE EVIDENCE LAYER

© 2026 Rembrandt. All rights reserved.

Light where it matters.

Mindmapp BV, 1017 VN, Weesperstraat 107, Amsterdam, the Netherlands

Rembrandt

REMBRANDT — THE EVIDENCE LAYER

© 2026 Rembrandt. All rights reserved.